Predictors of ovarian cancer survival: A population-based prospective study in Sweden

International Journal of Cancer

Volumn 123, Issue 3, 2008, Pages 672-679

  Yang, Ling ^a,b   Klint, Åsa ^b,c   Lambe, Mats ^b,d   Bellocco, Rino ^b,e   Riman, Tomas ^f,g   Bergfeldt, Kjell ^h   Persson, Ingemar ^b,i   Weiderpass, Elisabete ^b,j  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRE FOR EPIDEMIOLOGY   (Sweden)

^d Regional Cancer Register   (Sweden)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f FALUN HOSPITAL   (Sweden)

^g Center for Clinical Research   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ MEDICAL PRODUCTS AGENCY   (Sweden)

^j Cancer Registry of Norway ^*  (Finland)

more..

Author keywords

Epithelial ovarian cancer; Prospective study; Risk factors; Survival; Sweden

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; OBESITY; ORAL CONTRACEPTION; OVARY CANCER; PARITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCTION; SMOKING; SWEDEN;

AGE FACTORS; AGED; BODY CONSTITUTION; BODY SIZE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIFE STYLE; MEDICAL RECORD LINKAGE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SWEDEN;

EID: 46049115889     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23429     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006;20:207-25.
3. Gertig D, Hunter D. Ovarian cancer. In: Adami H, Hunter D, Trichopoulos D, eds. Textbook of cancer epidemiology. Oxford: Oxford University Press, 2002:378-99.
4. Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 1998;49:695-707.
5. Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004;83:783-95.
6. Mills PK, Riordan DG, Cress RD. Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 2004;95:215-25.
7. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR. Risk factors for epithelial borderline ovarian tumours: results of a Swedish case-control study. Gynecol Oncol 2001;83:575-85.
8. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 2002;156:363-73.
9. Mills PK, Riordan DG, Cress RD, Goldsmith TF. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Cancer Detect Prev 2005;29:129-32.
10. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003;164:371-7.
11. Vainio H, Bianchini F. eds. International Agency for Research on Cancer. Weight control and physical activity. In: IARC handbooks of cancer prevention. Lyon: IARC Press, 2002;95-154.
12. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002;94:497-504.
13. Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004;19:1011-19.
14. Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Age at natural menopause and the risk of epithelial ovarian cancer. Obstet Gynecol 2001;98:85-90.
15. Weiderpass E, Margolis KL, Sandin S, Braaten T, Kumle M, Adami HO, Lund E. Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 2006;118:3153-60.
16. Clark TG, Stewart ME, Altman DG, Gabra H, Smyth JF. A prognostic model for ovarian cancer. Br J Cancer 2001;85:944-52.
17. Eisenhauer EA, Gore M, Neijt JP. Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner? Ann Oncol 1999;10(Suppl 1):9-15.
18. Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 2000;19:3-10.
19. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003;101:885-91.
20. Jacobsen B, Vollset SE, Kvale G. Reproductive factors and survival from ovarian cancer. Int J Cancer 1993;54:904-6.
21. Kjaerbye-Thygesen A, Frederiksen K, Hogdall EV, Glud E, Christensen L, Hogdall CK, Blaakaer J, Kjaer SK. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2006;15:798-803.
22. Mascarenhas C, Lambe M, Bellocco R, Bergfeldt K, Riman T, Persson I, Weiderpass E. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival. Int J Cancer 2006;119:2907-15.
23. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ. Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:822-8.
24. Vessey M, Painter R, Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 2003;362:185-91.
25. Zhang M, Xie X, Lee AH, Binns CW, Holman CD. Body mass index in relation to ovarian cancer survival. Cancer Epidemiol Biomarkers Prev 2005;14:1307-10.
26. Chu CS, Morgan MA, Randall TC, Bandera CA, Rubin SC. Survival of BRCA1 negative ovarian cancer patients based on family history. Gynecol Oncol 2001;83:109-14.
27. Zweemer RP, Verheijen RH, Coebergh JW, Jacobs IJ, van Diest PJ, Gille JJP, Skates S, Menko FH, Ten Kate LP, Kenemans P. Survival analysis in familial ovarian cancer, a case control study. Eur J Obstet Gynecol Reprod Biol 2001;98:219-23.
28. Kjaerbye-Thygesen A, Frederiksen K, Hogdall EV, Hogdall CK, Blaakaer J, Kjaer SK. Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables. Eur J Gynaecol Oncol 2006;27:467-72.
29. Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD, Li AJ. Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006;107:1520-4.
30. Nagle CM, Bain CJ, Webb PM. Cigarette smoking and survival after ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2006;15:2557-60.
31. Rock CL, Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr 2002;132: 3504S-3507S.
32. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, Trichopoulos D, Adami HO. Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 1998;76:29-34.
33. Themeau TM, Grambsch PM. Modelling survival data: extending the Cox model. New York: Springer, 2000.
34. Stata Statistical Software: Release 9. StataCorp. College Station, TX: StataCorp LP, 2005.
35. Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;82:532-7.